$JAGX News Article - Jaguar Health Exploring Possibility of Conditional Marketing Authorization for Proposed Inflammatory Diarrhea Indication for Crofelemer, Initially in 'Long-Hauler' COVID-19 Recovery Patients in Europe https://marketwirenews.com/news-releases/jagu...81164.html